Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-24 @ 11:45 PM
NCT ID:
NCT01122251
Eligibility Criteria:
Inclusion Criteria:
* Patients aged between 20 and 75
* Essential hypertension at screening (-3 week)
Randomization Criteria:
* Essential hypertension at baseline (90mmHg≤sitDBP≤109mmHg, except sitSBP≥180)
Exclusion Criteria:
* Mean sitDBP≥110mmHg or sitSBP≥180
* Secondary hypertension or suspected secondary hypertension
* Uncontrolled diabetes
* Severe heart disease or severe cerebrovascular disease
* clinically significant hematological test results, renal disease (serum creatinine) or liver disease (ALT or AST)
* History of malignant disease
* Autoimmune disease
* Women with a positive pregnancy test result, breast feeding or intention of pregnancy during the trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT01122251
Study Brief:
Protocol Section:
NCT01122251